RedHill Biopharma Completes Enrollment for COVID-19 U.S. Phase...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
TEL AVIV, Israel and RALEIGH, NC, Nov. 20, 2020 /PRNewswire-AsiaNet/ -- Enrollment completed in the U.S. Phase 2 study evaluating opaganib's safety and initial efficacy signal in 40 hospitalized patients with severe COVID-19 pneumoniaA parallel global Phase 2/3 study with orally administered opaganib for severe CO...
Authors: LATEST ASIANET NEWS RELEASES